MLA medical australia limited

just the start of stem cell apps. , page-8

  1. 1,046 Posts.
    lightbulb Created with Sketch. 40

    JSMAMA,I guess there could be the possibility of further dilution via a cap raising. Mgmt have been projecting becoming cash-flow positive the past two annual reports - so it all hinges on this. Can probably assume that if the business starts picking up then bank loan facility might cover any short term working capital requirements.

    However if they continue as they have been tracking I can't see that cash lasting much more than 2 quarters (I believe 132k was depreciation of the annual loss of -668k).

    It's all wait and see at the moment. I'm happy holding (only recently took a position after having watched for the past year and half)

    DYOR


    From the annual report:

    "Management has prepared a cash flow forecast for the 15 months ended September 2013 that supports the ability of the entity to continue as a going concern. These cash flow projections assume a 6.5% increase in sales and an extension of the bank loan facility. The cash flow points to a positive cash position at the send of September 2013. The Directors are presently satisfied that the projected cash flow will be achieved."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.